000 | 01762 a2200481 4500 | ||
---|---|---|---|
005 | 20250513131844.0 | ||
264 | 0 | _c19980106 | |
008 | 199801s 0 0 eng d | ||
022 | _a0020-9996 | ||
024 | 7 |
_a10.1097/00004424-199711000-00010 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aCasali, C | |
245 | 0 | 0 |
_aDesign of an isolated pig heart preparation for positron emission tomography and magnetic resonance imaging. _h[electronic resource] |
260 |
_bInvestigative radiology _cNov 1997 |
||
300 |
_a713-20 p. _bdigital |
||
500 | _aPublication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aChelating Agents _xpharmacokinetics |
650 | 0 | 4 |
_aContrast Media _xpharmacokinetics |
650 | 0 | 4 |
_aFluorodeoxyglucose F18 _xpharmacokinetics |
650 | 0 | 4 |
_aHeart _xdiagnostic imaging |
650 | 0 | 4 |
_aHeterocyclic Compounds _xpharmacokinetics |
650 | 0 | 4 | _aImage Processing, Computer-Assisted |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 |
_aMagnetic Resonance Imaging _xmethods |
650 | 0 | 4 |
_aMyocardium _xmetabolism |
650 | 0 | 4 | _aOrgan Size |
650 | 0 | 4 |
_aOrganometallic Compounds _xpharmacokinetics |
650 | 0 | 4 |
_aPerfusion _xmethods |
650 | 0 | 4 |
_aRadiopharmaceuticals _xpharmacokinetics |
650 | 0 | 4 | _aReproducibility of Results |
650 | 0 | 4 | _aResearch Design |
650 | 0 | 4 | _aSwine |
650 | 0 | 4 |
_aTomography, Emission-Computed _xmethods |
700 | 1 | _aObadia, J F | |
700 | 1 | _aCanet, E | |
700 | 1 | _aBendjelid, K | |
700 | 1 | _aAndré-Fouët, X | |
700 | 1 | _aRevel, D | |
700 | 1 | _aJanier, M F | |
773 | 0 |
_tInvestigative radiology _gvol. 32 _gno. 11 _gp. 713-20 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1097/00004424-199711000-00010 _zAvailable from publisher's website |
999 |
_c9356849 _d9356849 |